Table 2.
Clinical, endocrine, and metabolic characteristics of study population
| Non-PCOS (n = 32) | PCOS-C (n = 31) | PCOS-GH (n = 30) | |
|---|---|---|---|
| Age (yrs) | 29.59 ± 3.02 | 28.90 ± 2.86 | 28.17 ± 3.52 |
| Irregular menstrual cycle (n) a,b | 0 | 25 | 23 |
| Hirsutism (n) a,b | 0 | 7 | 6 |
| Acne (n) a,b | 0 | 16 | 16 |
| BMI (kg/m2) | 21.76 ± 2.50 | 22.12 ± 3.13 | 23.10 ± 2.27 |
| WHR a,b | 0.82 ± 0.05 | 0.85 ± 0.05 | 0.87 ± 0.06 |
| LH/FSH ratio a,b | 1.08 ± 0.56 | 1.55 ± 0.90 | 1.64 ± 1.00 |
| E2(pg/ml) | 46.52 ± 12.25 | 49.00 ± 13.33 | 45.14 ± 14.84 |
| P (ng/ml) | 0.52 ± 0.27 | 0.57 ± 0.23 | 0.45 ± 0.21 |
| TT (ng/ml)a,b | 0.49 ± 0.16 | 0.65 ± 0.32 | 0.66 ± 0.25 |
| SHBG (nmol/l) a,b | 83.43 ± 25.24 | 42.64 ± 25.02 | 48.09 ± 22.11 |
| FAI a,b | 2.13 ± 0.67 | 7.22 ± 4.23 | 7.13 ± 6.64 |
| FPG (mmol/l) | 4.80 ± 0.41 | 5.04 ± 0.52 | 5.11 ± 0.63 |
| FINS (mIU/l) a,b | 8.11 ± 2.57 | 11.51 ± 6.52 | 11.51 ± 6.40 |
| HOMA-IR a,b | 1.76 ± 0.70 | 2.54 ± 1.37 | 2.65 ± 1.55 |
Data are presented as mean ± SD or number (percentage). Abbreviations: BMI body mass index, WHR waist-to-hip ratio, FSH follicle stimulating hormone, LH luteinizing hormone, E2 estradiol, P progesterone, TT total testosterone, SHBG sex hormone binding globulin, FAI free androgen index, FPG fasting plasma glucose, FINS Fasting insulin, HOMA-IR homeostatic model assessment of insulin resistance.
a P < 0.05, non-PCOS group versus PCOS-C group
b P < 0.05, non-PCOS group versus PCOS-GH group